{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:57:45Z","timestamp":1792670265339,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["DS 329"],"award-info":[{"award-number":["DS 329"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13048-018-0420-1","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T10:44:09Z","timestamp":1527849849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve \u2013 an observational study"],"prefix":"10.1186","volume":"11","author":[{"given":"Piotr","family":"Czuczwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3241-3411","authenticated-orcid":false,"given":"Anna","family":"Stepniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Milart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Paszkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomir","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"420_CR1","unstructured":"Matchar DB, Myers ER, Barber MW, Couchman GM, Datta S, Gray RN, et al. Management of uterine fibroids. Evid Rep Technol Assess. 2001;34"},{"key":"420_CR2","doi-asserted-by":"crossref","unstructured":"Tropeano G, Amoroso S, Scambia G. Non-surgical management of uterine fibroids. Hum Reprod Update. 14(3)","DOI":"10.1093\/humupd\/dmn006"},{"key":"420_CR3","doi-asserted-by":"crossref","unstructured":"Donnez J, Donnez O, Dolmans MM. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertil Steril. 2014;102","DOI":"10.1016\/j.fertnstert.2014.06.041"},{"key":"420_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ajog.2013.07.017","volume":"209","author":"BJ Borah","year":"2013","unstructured":"Borah BJ, Nicholson WK, Bradley L, Stewart EA. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209:319.","journal-title":"Am J Obstet Gynecol"},{"key":"420_CR5","doi-asserted-by":"crossref","unstructured":"Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol. 2005;162","DOI":"10.1093\/aje\/kwi324"},{"key":"420_CR6","doi-asserted-by":"crossref","unstructured":"Jacob GP, Oraif A, Power S. When helping hurts: the effect of surgical interventions on ovarian reserve. Hum Fertil. 2016;19","DOI":"10.3109\/14647273.2016.1148826"},{"key":"420_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1477-7827-12-125","volume":"12","author":"A Iwase","year":"2014","unstructured":"Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Assessment of ovarian reserve using anti-M\u00fcllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review. Reprod Biol Endocrinol. 2014;12:125.","journal-title":"Reprod Biol Endocrinol"},{"key":"420_CR8","doi-asserted-by":"crossref","unstructured":"Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P. Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2007;92","DOI":"10.1210\/jc.2006-2816"},{"key":"420_CR9","doi-asserted-by":"crossref","unstructured":"Donnez J, Donnez O, Matule D, Ahrendt HJ, Hudecek R, Zatik J, et al. Long-term medical management of uterine fibroids with ulipristal acetate. Fertil Steril. 2016;105","DOI":"10.1016\/j.fertnstert.2015.09.032"},{"key":"420_CR10","doi-asserted-by":"crossref","unstructured":"Singh S, Best C, Dunn S, Leyland N, Wolfmann WL. Abnormal uterine bleeding in women. JOGC. 2013;35","DOI":"10.1016\/S1701-2163(15)30939-7"},{"key":"420_CR11","doi-asserted-by":"crossref","unstructured":"SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004. Int J Gynaecol Obstet. 2005;89","DOI":"10.1016\/j.ijgo.2005.03.013"},{"key":"420_CR12","doi-asserted-by":"crossref","unstructured":"Carranza-Mamane B, Havelock J, Hemmings R. The Management of Uterine Fibroids in women with otherwise unexplained infertility. Clinical, Sogc Guideline, Practice J Obs Gynaecol Can. 2015;37","DOI":"10.1016\/S1701-2163(15)30318-2"},{"key":"420_CR13","doi-asserted-by":"crossref","unstructured":"Broekmans FJM, De Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94","DOI":"10.1016\/j.fertnstert.2009.04.040"},{"key":"420_CR14","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2012;98","DOI":"10.1016\/j.fertnstert.2012.09.036"},{"key":"420_CR15","doi-asserted-by":"crossref","unstructured":"Fenton A, Panay N. Does routine gynecological surgery contribute to an early menopause? Climacteric. 2012;15","DOI":"10.3109\/13697137.2012.647623"},{"key":"420_CR16","doi-asserted-by":"crossref","unstructured":"Moorman PG, Myers ER, Schildkraut JM, Iversen ES, Wang F, Warren N. Effect of hysterectomy with ovarian preservation on ovarian function. Obstet Gynecol. 2011;118","DOI":"10.1097\/AOG.0b013e318236fd12"},{"key":"420_CR17","doi-asserted-by":"crossref","unstructured":"Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol. 2008;31","DOI":"10.1007\/s00270-007-9195-2"},{"key":"420_CR18","doi-asserted-by":"crossref","unstructured":"Hehenkamp WJ, Volkers NA, Broekmans FJ, de Jong FH, Themmen APN, Birnie E, et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Hum Reprod. 2007;22","DOI":"10.1093\/humrep\/dem105"},{"key":"420_CR19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajog.2016.06.051","volume":"215","author":"AM de Bruijn","year":"2016","unstructured":"de Bruijn AM, Ankum WM, Reekers JA, Birnie E, van der Kooij SM, Volkers NA, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol. 2016;215:745.","journal-title":"Am J Obstet Gynecol"},{"key":"420_CR20","doi-asserted-by":"crossref","unstructured":"Tropeano G, Di Stasi C, Amoroso S, Gualano MR, Bonomo L, Scambia G. Long-term effects of uterine fibroid embolization on ovarian reserve: a prospective cohort study. Fertil Steril. 2010;94","DOI":"10.1016\/j.fertnstert.2009.12.007"},{"key":"420_CR21","doi-asserted-by":"crossref","unstructured":"Tsikouras P, Manav B, Koukouli Z, Trypsiannis G, Galazios G, Souftas D, et al. Ovarian reserve after fibroid embolization in premenopausal women. Minim Invasive Ther Allied Technol. 2017;","DOI":"10.1080\/13645706.2017.1292919"},{"key":"420_CR22","doi-asserted-by":"crossref","unstructured":"Kim C-W, Shim HS, Jang H, Song YG. The effects of uterine artery embolization on ovarian reserve. Eur J Obstet Gynecol Reprod Biol. 2016;206","DOI":"10.1016\/j.ejogrb.2016.09.001"},{"key":"420_CR23","doi-asserted-by":"crossref","unstructured":"Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. BJOG. 2005;112","DOI":"10.1111\/j.1471-0528.2005.00696.x"},{"key":"420_CR24","doi-asserted-by":"crossref","unstructured":"Trabuco EC, Moorman PG, Algeciras-Schimnich A, Weaver AL, Cliby WA. Association of Ovary-Sparing Hysterectomy with Ovarian Reserve. Obstet Gynecol. 2016;127","DOI":"10.1097\/AOG.0000000000001398"},{"key":"420_CR25","doi-asserted-by":"crossref","unstructured":"Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anastos K, Watts DH, et al. Variations in serum m\u00fcllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril. 2009;92","DOI":"10.1016\/j.fertnstert.2008.08.110"},{"key":"420_CR26","doi-asserted-by":"crossref","unstructured":"Donnez J, Dolmans M-M. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016;1","DOI":"10.1093\/humupd\/dmw023"},{"key":"420_CR27","doi-asserted-by":"crossref","unstructured":"Luyckx M, Squifflet J-L, Jadoul P, Votino R, Dolmans M-M, Donnez J. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids. Fertil Steril. 2014;102","DOI":"10.1016\/j.fertnstert.2014.07.1253"},{"key":"420_CR28","doi-asserted-by":"crossref","unstructured":"Czuczwar P, Wo\u017aniak S, Szkodziak P, Wozniakowska E, Paszkowski M, Wrona W, et al. Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease. Prz Menopauzalny. 2014;13","DOI":"10.5114\/pm.2014.45001"},{"key":"420_CR29","doi-asserted-by":"crossref","unstructured":"Fauser BCJM, Donnez J, Bouchard P, Barlow DH, Vazquez F, Arriagada P, et al. Safety after extended repeated use of ulipristal acetate for uterine fibroids. PLoS One. 2017;12","DOI":"10.1371\/journal.pone.0173523"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-018-0420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-018-0420-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-018-0420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T20:17:00Z","timestamp":1571429820000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-018-0420-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1186\/s13048-018-0420-1","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"22 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work has been approved by the ethics committee of Medical University of Lublin, and informed consent for publication was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"45"}}